{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Nixa",
      "state": "MO",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67228",
      "recalling_firm": "Schindele Enterprises dba Midwest Wholesale",
      "address_1": "617 N Althea Ave",
      "address_2": "N/A",
      "postal_code": "65714-7432",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI",
      "recall_number": "D-1340-2014",
      "product_description": "XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.",
      "product_quantity": "89 blister packs",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.",
      "recall_initiation_date": "20140109",
      "center_classification_date": "20140520",
      "termination_date": "20150203",
      "report_date": "20140528",
      "code_info": "Lot 130520PL Exp. 05/31/2017"
    }
  ]
}